Pharmaceuticals
Denmark's Medicine Limits Threaten Life Sciences Sector
Pharmaceutical industry leaders warn that medicine access restrictions could drive investment away from Denmark's life sciences sector. The debate centers on Medicine Board guidelines and their economic fallout.
Børsen